Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10238-024-01550-6.

Title:
Donafenib activates the p53 signaling pathway in hepatocellular carcinoma, induces ferroptosis, and enhances cell apoptosis | Clinical and Experimental Medicine
Description:
Donafenib is an improved version of sorafenib in which deuterium is substituted into the drug’s chemical structure, enhancing its stability and antitumor activity. Donafenib exhibits enhanced antitumor activity and better tolerance than sorafenib in preclinical and clinical studies. However, the specific mechanism of its effect on hepatocellular carcinoma has not been reported. Iron deposition is a cell death pattern caused by disturbances in iron metabolism. Apoptosis is a form of programmed cell death. They may interact with each other during cell death. This study mainly explores the potential mechanism of donafenib activating the p53 signaling pathway, inducing iron deposition, and enhancing cell apoptosis in hepatocellular carcinoma. Hepa1-6 and Huh7 cells were treated with various concentrations of donafenib. Scratch healing and pore migration tests were conducted. Analyze apoptosis through flow cytometry and TUNEL fluorescence labeling. RNA sequencing was conducted on both untreated and donafenib-treated Huh7 cells. The key proteins involved in ferroptosis (SLC7A11, GPX4) and apoptosis (caspase3, caspase8, Bax, Bcl-2, p53) were then evaluated using immunoblotting and immunohistochemical staining. Reactive oxygen species (ROS) levels in the cancer cells were measured. Donafenib treatment resulted in a dose-dependent decrease in the proliferation, migration, and invasion capabilities of cancer cells. There was an increase in apoptosis rates and ROS accumulation, and a reduction in tumor volume. The key proteins involved in ferroptosis and apoptosis underwent significant changes. Donafenib activates the p53 signaling pathway, induce ferroptosis, and enhance apoptosis, suggesting its potential as an effective therapeutic agent for HCC.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

donafenib, cells, cell, cancer, apoptosis, pubmed, liver, article, huh, google, scholar, group, analysis, hepa, ferroptosis, death, tumor, expression, treatment, concentration, cas, iron, fig, caspase, signaling, increased, central, slca, effect, protein, proteins, ros, genes, gpx, data, concentrations, culture, pathway, hcc, medium, gradually, hepatocellular, carcinoma, proliferation, drug, promote, inhibit, mice, size, full,

Topics {✒️}

article download pdf trim28-mdm2-dependent manner phase ii-iii studies controlled light–dark cycle tyrosine kinase inhibitors cysteine/glutamate reverse transporters endogenous apoptosis-dependent pathways cystine transporter slc7a11/xct anti-apoptotic protein bcl-2 pan-cancer analyses confirmed proposed tumor-suppressive function pd-l1 monoclonal antibody late-stage apoptotic cells donafenib induces anti-angiogenesis iron death-related proteins privacy choices/manage cookies reactive oxygen species direct proportional relationship transwell migration/invasion assay multiple apoptosis-related proteins iron death-related mechanisms dose-dependent relationship guangxi medical university purified pcr products fatty acid metabolism advanced liver cancer bca reagent kit references colyn ferroptosis-related gene slc7a11 apoptosis-related proteins caspase3 nat rev cancer reprogramming lipid metabolism cell counting kit-8 full access experimental medicine aims guangxi key laboratory significant differential genes central hub trends cell biol including antioxidant defense differentially expressed genes enhances cell apoptosis pathogen-free environment oxidative stress signals programmed cell death dose-dependent decrease triggering iron deposition apoptotic cell death cell viability assay disability-adjusted life years

Questions {❓}

  • The role of SLC7A11 in cancer: Friend or foe?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Donafenib activates the p53 signaling pathway in hepatocellular carcinoma, induces ferroptosis, and enhances cell apoptosis
         description:Donafenib is an improved version of sorafenib in which deuterium is substituted into the drug’s chemical structure, enhancing its stability and antitumor activity. Donafenib exhibits enhanced antitumor activity and better tolerance than sorafenib in preclinical and clinical studies. However, the specific mechanism of its effect on hepatocellular carcinoma has not been reported. Iron deposition is a cell death pattern caused by disturbances in iron metabolism. Apoptosis is a form of programmed cell death. They may interact with each other during cell death. This study mainly explores the potential mechanism of donafenib activating the p53 signaling pathway, inducing iron deposition, and enhancing cell apoptosis in hepatocellular carcinoma. Hepa1-6 and Huh7 cells were treated with various concentrations of donafenib. Scratch healing and pore migration tests were conducted. Analyze apoptosis through flow cytometry and TUNEL fluorescence labeling. RNA sequencing was conducted on both untreated and donafenib-treated Huh7 cells. The key proteins involved in ferroptosis (SLC7A11, GPX4) and apoptosis (caspase3, caspase8, Bax, Bcl-2, p53) were then evaluated using immunoblotting and immunohistochemical staining. Reactive oxygen species (ROS) levels in the cancer cells were measured. Donafenib treatment resulted in a dose-dependent decrease in the proliferation, migration, and invasion capabilities of cancer cells. There was an increase in apoptosis rates and ROS accumulation, and a reduction in tumor volume. The key proteins involved in ferroptosis and apoptosis underwent significant changes. Donafenib activates the p53 signaling pathway, induce ferroptosis, and enhance apoptosis, suggesting its potential as an effective therapeutic agent for HCC.
         datePublished:2025-01-03T00:00:00Z
         dateModified:2025-01-03T00:00:00Z
         pageStart:1
         pageEnd:20
         license:http://creativecommons.org/licenses/by-nc-nd/4.0/
         sameAs:https://doi.org/10.1007/s10238-024-01550-6
         keywords:
            Hepatocellular carcinoma
            Donafenib
            p53
            Ferroptosis
            Cell apoptosis
            Internal Medicine
            Hematology
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig8_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig9_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig10_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig11_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig12_HTML.png
         isPartOf:
            name:Clinical and Experimental Medicine
            issn:
               1591-9528
            volumeNumber:25
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer International Publishing
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jiaming Liang
               affiliation:
                     name:the First Affiliated Hospital of Guangxi Medical University
                     address:
                        name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Meifeng Chen
               affiliation:
                     name:the First Affiliated Hospital of Guangxi Medical University
                     address:
                        name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Guohong Yan
               affiliation:
                     name:the First Affiliated Hospital of Guangxi Medical University
                     address:
                        name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Pham Thi Thai Hoa
               affiliation:
                     name:Guangxi International Zhuang Medical Hospital
                     address:
                        name:Research and Development Centre of Zhuang and Yao Medicines, Guangxi International Zhuang Medical Hospital, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shuxin Wei
               affiliation:
                     name:Guangxi Medical University
                     address:
                        name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hailian Huang
               affiliation:
                     name:Guangxi Medical University
                     address:
                        name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Qichong Xie
               affiliation:
                     name:Guangxi Medical University
                     address:
                        name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiaoling Luo
               affiliation:
                     name:Guangxi Medical University
                     address:
                        name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shutian Mo
               affiliation:
                     name:the First Affiliated Hospital of Guangxi Medical University
                     address:
                        name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Chuangye Han
               affiliation:
                     name:the First Affiliated Hospital of Guangxi Medical University
                     address:
                        name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Donafenib activates the p53 signaling pathway in hepatocellular carcinoma, induces ferroptosis, and enhances cell apoptosis
      description:Donafenib is an improved version of sorafenib in which deuterium is substituted into the drug’s chemical structure, enhancing its stability and antitumor activity. Donafenib exhibits enhanced antitumor activity and better tolerance than sorafenib in preclinical and clinical studies. However, the specific mechanism of its effect on hepatocellular carcinoma has not been reported. Iron deposition is a cell death pattern caused by disturbances in iron metabolism. Apoptosis is a form of programmed cell death. They may interact with each other during cell death. This study mainly explores the potential mechanism of donafenib activating the p53 signaling pathway, inducing iron deposition, and enhancing cell apoptosis in hepatocellular carcinoma. Hepa1-6 and Huh7 cells were treated with various concentrations of donafenib. Scratch healing and pore migration tests were conducted. Analyze apoptosis through flow cytometry and TUNEL fluorescence labeling. RNA sequencing was conducted on both untreated and donafenib-treated Huh7 cells. The key proteins involved in ferroptosis (SLC7A11, GPX4) and apoptosis (caspase3, caspase8, Bax, Bcl-2, p53) were then evaluated using immunoblotting and immunohistochemical staining. Reactive oxygen species (ROS) levels in the cancer cells were measured. Donafenib treatment resulted in a dose-dependent decrease in the proliferation, migration, and invasion capabilities of cancer cells. There was an increase in apoptosis rates and ROS accumulation, and a reduction in tumor volume. The key proteins involved in ferroptosis and apoptosis underwent significant changes. Donafenib activates the p53 signaling pathway, induce ferroptosis, and enhance apoptosis, suggesting its potential as an effective therapeutic agent for HCC.
      datePublished:2025-01-03T00:00:00Z
      dateModified:2025-01-03T00:00:00Z
      pageStart:1
      pageEnd:20
      license:http://creativecommons.org/licenses/by-nc-nd/4.0/
      sameAs:https://doi.org/10.1007/s10238-024-01550-6
      keywords:
         Hepatocellular carcinoma
         Donafenib
         p53
         Ferroptosis
         Cell apoptosis
         Internal Medicine
         Hematology
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig8_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig9_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig10_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig11_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10238-024-01550-6/MediaObjects/10238_2024_1550_Fig12_HTML.png
      isPartOf:
         name:Clinical and Experimental Medicine
         issn:
            1591-9528
         volumeNumber:25
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jiaming Liang
            affiliation:
                  name:the First Affiliated Hospital of Guangxi Medical University
                  address:
                     name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Meifeng Chen
            affiliation:
                  name:the First Affiliated Hospital of Guangxi Medical University
                  address:
                     name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Guohong Yan
            affiliation:
                  name:the First Affiliated Hospital of Guangxi Medical University
                  address:
                     name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Pham Thi Thai Hoa
            affiliation:
                  name:Guangxi International Zhuang Medical Hospital
                  address:
                     name:Research and Development Centre of Zhuang and Yao Medicines, Guangxi International Zhuang Medical Hospital, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shuxin Wei
            affiliation:
                  name:Guangxi Medical University
                  address:
                     name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hailian Huang
            affiliation:
                  name:Guangxi Medical University
                  address:
                     name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Qichong Xie
            affiliation:
                  name:Guangxi Medical University
                  address:
                     name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiaoling Luo
            affiliation:
                  name:Guangxi Medical University
                  address:
                     name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shutian Mo
            affiliation:
                  name:the First Affiliated Hospital of Guangxi Medical University
                  address:
                     name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Chuangye Han
            affiliation:
                  name:the First Affiliated Hospital of Guangxi Medical University
                  address:
                     name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Clinical and Experimental Medicine
      issn:
         1591-9528
      volumeNumber:25
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:the First Affiliated Hospital of Guangxi Medical University
      address:
         name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:the First Affiliated Hospital of Guangxi Medical University
      address:
         name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:the First Affiliated Hospital of Guangxi Medical University
      address:
         name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:Guangxi International Zhuang Medical Hospital
      address:
         name:Research and Development Centre of Zhuang and Yao Medicines, Guangxi International Zhuang Medical Hospital, Nanning, China
         type:PostalAddress
      name:Guangxi Medical University
      address:
         name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:Guangxi Medical University
      address:
         name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:Guangxi Medical University
      address:
         name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:Guangxi Medical University
      address:
         name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:the First Affiliated Hospital of Guangxi Medical University
      address:
         name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
         type:PostalAddress
      name:the First Affiliated Hospital of Guangxi Medical University
      address:
         name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jiaming Liang
      affiliation:
            name:the First Affiliated Hospital of Guangxi Medical University
            address:
               name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
      name:Meifeng Chen
      affiliation:
            name:the First Affiliated Hospital of Guangxi Medical University
            address:
               name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
      name:Guohong Yan
      affiliation:
            name:the First Affiliated Hospital of Guangxi Medical University
            address:
               name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
      name:Pham Thi Thai Hoa
      affiliation:
            name:Guangxi International Zhuang Medical Hospital
            address:
               name:Research and Development Centre of Zhuang and Yao Medicines, Guangxi International Zhuang Medical Hospital, Nanning, China
               type:PostalAddress
            type:Organization
      name:Shuxin Wei
      affiliation:
            name:Guangxi Medical University
            address:
               name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
      name:Hailian Huang
      affiliation:
            name:Guangxi Medical University
            address:
               name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
      name:Qichong Xie
      affiliation:
            name:Guangxi Medical University
            address:
               name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
      name:Xiaoling Luo
      affiliation:
            name:Guangxi Medical University
            address:
               name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
      name:Shutian Mo
      affiliation:
            name:the First Affiliated Hospital of Guangxi Medical University
            address:
               name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Chuangye Han
      affiliation:
            name:the First Affiliated Hospital of Guangxi Medical University
            address:
               name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
      name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
      name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
      name:Research and Development Centre of Zhuang and Yao Medicines, Guangxi International Zhuang Medical Hospital, Nanning, China
      name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
      name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
      name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
      name:School of Basic Medical Sciences, Guangxi Medical University, Nanning, China
      name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China
      name:Department of Hepatobiliary Surgery, the First Affiliated Hospital of Guangxi Medical University, Nanning, China

External Links {🔗}(227)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.37s.